Fortis Healthcare Limited , a leading player in the Indian healthcare sector, has received final approval from the National Company Law Tribunals (NCLTs) for its composite scheme of merger by absorption involving multiple wholly-owned subsidiaries.

NCLT Approval Timeline

The company has secured approvals from both jurisdictional NCLTs for the restructuring scheme:

Entities Involved in the Merger

The scheme involves the merger of four wholly-owned subsidiaries into Fortis Hospitals Limited (FHsL):

Financial Details of Subsidiaries

The financial profile of the entities involved in the merger shows varying scales of operations:

Strategic Rationale and Implementation

The merger aims to achieve operational rationalization and cost optimization through simplified management structures and streamlined financial reporting. The scheme will become effective once certified copies of both NCLT orders are filed with the jurisdictional Registrar of Companies.

Since all transferor companies are wholly-owned subsidiaries of FHsL, the merger will not involve any share issuance or cash consideration. The shareholding pattern of Fortis Healthcare Limited, the listed entity, will remain unchanged following this internal restructuring.

Regulatory Compliance

The transaction falls under related party arrangements but is exempt from Section 188 requirements of the Companies Act, 2013, as per MCA General Circular No. 30/2014. Additionally, related party transaction provisions under SEBI LODR Regulations do not apply to this scheme under Regulation 23(5)(c).

Fortis Healthcare Limited announced a significant expansion in its healthcare portfolio as its wholly-owned subsidiary, Fortis Hospotel Limited (FHTL), successfully completed the acquisition of Shrimann Superspecialty Hospital's entire business operations. The transaction, which includes the hospital land and adjacent property, was finalized on July 24, 2025, at 09:14 PM IST.

Acquisition Details

The completion of this acquisition marks a crucial milestone for Fortis Healthcare, following a series of strategic moves earlier in the year. The company had previously disclosed information about the transaction through intimations to the stock exchanges in February, March, and May 2025, detailing the definitive agreements for this significant acquisition.

Regulatory Compliance

In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, Fortis Healthcare Limited promptly informed the National Stock Exchange of India Ltd. and BSE Limited about the successful consummation of the transaction. The disclosure was made through an official letter signed by Satyendra Chauhan, the Company Secretary & Compliance Officer of Fortis Healthcare Limited.

Strategic Implications

This acquisition is expected to strengthen Fortis Healthcare's market position and expand its healthcare services portfolio. By incorporating Shrimann Superspecialty Hospital's operations and assets, Fortis is poised to enhance its capabilities in specialized medical care and potentially increase its market share in the region.

Looking Ahead

While specific financial details of the transaction were not disclosed in the announcement, the acquisition of an entire hospital operation, including land and property, suggests a significant investment by Fortis Healthcare. This move aligns with the company's growth strategy and may lead to expanded service offerings and increased patient capacity in the future.

Investors and stakeholders will likely be watching closely to see how this acquisition impacts Fortis Healthcare's operational performance and market presence in the coming quarters.